statistiche ricercatore

Continente	#
EU - Europa	638
NA - Nord America	529
AS - Asia	316
SA - Sud America	58
Continente sconosciuto - Info sul continente non disponibili	31
AF - Africa	13
Totale	1.585

Nazione	#
US - Stati Uniti d'America	504
RU - Federazione Russa	397
SG - Singapore	132
IT - Italia	67
CN - Cina	65
IE - Irlanda	60
BR - Brasile	52
SE - Svezia	37
BD - Bangladesh	27
HK - Hong Kong	24
VN - Vietnam	24
DE - Germania	19
IN - India	15
FR - Francia	12
CA - Canada	11
GB - Regno Unito	11
AT - Austria	7
MX - Messico	7
FI - Finlandia	6
CZ - Repubblica Ceca	5
PL - Polonia	5
ZA - Sudafrica	5
JP - Giappone	4
PH - Filippine	3
SA - Arabia Saudita	3
TR - Turchia	3
AE - Emirati Arabi Uniti	2
CO - Colombia	2
EC - Ecuador	2
EE - Estonia	2
EG - Egitto	2
ID - Indonesia	2
MA - Marocco	2
MY - Malesia	2
NL - Olanda	2
PK - Pakistan	2
TT - Trinidad e Tobago	2
UZ - Uzbekistan	2
AM - Armenia	1
BB - Barbados	1
BE - Belgio	1
BO - Bolivia	1
BY - Bielorussia	1
CI - Costa d'Avorio	1
CR - Costa Rica	1
DZ - Algeria	1
ES - Italia	1
GR - Grecia	1
GT - Guatemala	1
HN - Honduras	1
IQ - Iraq	1
JM - Giamaica	1
KE - Kenya	1
LA - Repubblica Popolare Democratica del Laos	1
LK - Sri Lanka	1
MK - Macedonia	1
NG - Nigeria	1
NO - Norvegia	1
OM - Oman	1
PT - Portogallo	1
TH - Thailandia	1
UA - Ucraina	1
UY - Uruguay	1
Totale	1.554

Nome	#
Seeking new approach for therapeutic treatment of cholera disease via inhibition of bacterial carbonic anhydrases: experimental and theoretical studies for sixteen benzenesulfonamide derivatives	199
Exploring structural properties of potent human carbonic anhydrase inhibitors bearing a 4-(cycloalkylamino-1-carbonyl)benzenesulfonamide moiety	197
P158-DEVELOPMENT OF FLEXIBLE ARYLSULFONAMIDES AS POTENTIAL MULTITARGET ANTICANCER AGENTS	197
4-Sulfamoylphenylalkylamides as Inhibitors of Carbonic Anhydrases Expressed in Vibrio cholerae	194
Synthesis and biological evaluation of sulfonamide-based compounds as inhibitors of carbonic anhydrase from Vibrio cholerae	172
Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII	135
Synthesis, biochemical screening and in-silico investigations of arylsulfonamides bearing linear and cyclic tails	116
Exploring nutritional supplement use for countering respiratory tract infections through an X (formerly Twitter)-based survey	114
O-derivatization of natural tropolone and β-thujaplicin leading to effective inhibitors of human carbonic anhydrases IX and XII	111
Structure-guided identification of a selective sulfonamide-based inhibitor targeting the human carbonic anhydrase VA isoform	108
null	29
1-Aryl-6,7-Dimethoxy-3,4-Dihydroisoquinoline-2(1H)-Sulfonamides as hCA XII Selective Inhibitors: Experimental and Theoretical Studies to Interrogate the Isoform Selectivity	13
Totale	1.585

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	42	0	0	0	0	3	3	8	2	0	8	6	12
2022/2023	172	7	15	4	24	6	16	1	10	74	3	3	9
2023/2024	43	2	6	4	7	1	8	1	0	1	8	1	4
2024/2025	220	5	3	3	12	11	3	21	31	40	16	36	39
2025/2026	914	65	40	62	60	77	182	106	128	107	40	11	36
2026/2027	127	8	36	41	39	3	0	0	0	0	0	0	0
Totale													1.585